Literature DB >> 6736050

Design and analysis of accelerated degradation tests for the stability of biological standards III. Principles of design.

T B Kirkwood.   

Abstract

The principles of designing an accelerated degradation test for a biological standard are considered, with special emphasis on ensuring accuracy and precision of the predicted low temperature degradation rate. A three-stage design is proposed which initially monitors samples at the highest of the elevated temperatures, but which switches attention progressively to the lower temperatures as degradation begins to be detected. The advantages of this design over one where testing is carried out after a predetermined period are that it is (i) more efficient, (ii) more reliable and (iii) better suited to test the assumptions which underly the analysis of the results. Consideration is also given to additional checks which can be made on the stability of biological standards and to methods of monitoring long-term stability after the standard has been set up.

Mesh:

Substances:

Year:  1984        PMID: 6736050     DOI: 10.1016/s0092-1157(84)80056-6

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  4 in total

Review 1.  Biobanking.

Authors:  John G Day; Glyn N Stacey
Journal:  Mol Biotechnol       Date:  2008-09-09       Impact factor: 2.695

2.  Post-extraction stabilization of HIV viral RNA for quantitative molecular tests.

Authors:  Daniel S Stevens; Christopher H Crudder; Gonzalo J Domingo
Journal:  J Virol Methods       Date:  2012-03-13       Impact factor: 2.014

3.  Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis.

Authors:  Sally Bevan; Colin Longstaff
Journal:  J Thromb Haemost       Date:  2021-11-24       Impact factor: 16.036

4.  Dried blood spots as a source of anti-malarial antibodies for epidemiological studies.

Authors:  Patrick H Corran; Jackie Cook; Caroline Lynch; Heleen Leendertse; Alphaxard Manjurano; Jamie Griffin; Jonathan Cox; Tarekegn Abeku; Teun Bousema; Azra C Ghani; Chris Drakeley; Eleanor Riley
Journal:  Malar J       Date:  2008-09-30       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.